reboxetine has been researched along with Panic Attacks in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A | 1 |
Bellodi, L; Calati, R; Chiesa, A; De Ronchi, D; Perna, G; Serretti, A | 1 |
Dannon, PN; Grunhaus, L; Iancu, I | 1 |
Mohr, N; Muller, JE; Seedat, S; Stein, DJ; van Rheede van Oudtshoorn, E | 1 |
Bellodi, L; Bertani, A; Caldirola, D; Di Pasquale, D; Migliarese, G; Perna, G | 1 |
Bellodi, L; Bertani, A; Caldirola, D; Cucchi, M; Di Pasquale, D; Migliarese, G; Perna, G | 1 |
Schatzberg, AF | 1 |
Benedetti, A; Cassano, G; Mastalli, L; Nardi, A; Perugi, G; Savino, M; Versiani, M | 1 |
3 review(s) available for reboxetine and Panic Attacks
Article | Year |
---|---|
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2023 |
Novel antidepressants and panic disorder: evidence beyond current guidelines.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Morpholines; Panic Disorder; Practice Guidelines as Topic; Reboxetine; Thiophenes | 2011 |
Clinical efficacy of reboxetine in major depression.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Imipramine; Morpholines; Norepinephrine; Panic Disorder; Placebos; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2000 |
5 trial(s) available for reboxetine and Panic Attacks
Article | Year |
---|---|
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study.
Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Antidepressive Agents; Drug Resistance; Female; Humans; Male; Morpholines; Panic Disorder; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors | 2002 |
Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Adult; Citalopram; Comorbidity; Cross-Over Studies; Depression; Female; Humans; Male; Middle Aged; Morpholines; Panic Disorder; Pilot Projects; Reboxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome | 2003 |
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study.
Topics: Adolescent; Adult; Analysis of Variance; Bronchial Hyperreactivity; Carbon Dioxide; Chi-Square Distribution; Double-Blind Method; Female; Humans; Male; Morpholines; Panic Disorder; Paroxetine; Reboxetine; Statistics, Nonparametric | 2004 |
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study.
Topics: Adrenergic Uptake Inhibitors; Adult; Female; Humans; Male; Morpholines; Panic Disorder; Paroxetine; Psychometrics; Reboxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method | 2004 |
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.
Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Comorbidity; Constipation; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia | 2002 |